Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice

The direct oral anticoagulants (DOACs), dabigatran, rivaroxaban, apixaban, and edoxaban, are becoming the most commonly prescribed drugs for preventing ischemic stroke in patients with non-valvular atrial fibrillation (NVAF) and for the treatment and prevention of venous thromboembolism (VTE). Rivar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferri, Nicola, Colombo, Elisa, Tenconi, Marco, Baldessin, Ludovico, Corsini, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229376/
https://www.ncbi.nlm.nih.gov/pubmed/35745692
http://dx.doi.org/10.3390/pharmaceutics14061120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229376/
https://www.ncbi.nlm.nih.gov/pubmed/35745692
http://dx.doi.org/10.3390/pharmaceutics14061120

Ejemplares similares